ATE76291T1 - Stabilisierte makrolidzusammensetzungen. - Google Patents

Stabilisierte makrolidzusammensetzungen.

Info

Publication number
ATE76291T1
ATE76291T1 AT89301547T AT89301547T ATE76291T1 AT E76291 T1 ATE76291 T1 AT E76291T1 AT 89301547 T AT89301547 T AT 89301547T AT 89301547 T AT89301547 T AT 89301547T AT E76291 T1 ATE76291 T1 AT E76291T1
Authority
AT
Austria
Prior art keywords
macrolide compositions
stabilized
stabilized macrolide
compositions
compounds
Prior art date
Application number
AT89301547T
Other languages
English (en)
Inventor
David Thomas Eastlick
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of ATE76291T1 publication Critical patent/ATE76291T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Agronomy & Crop Science (AREA)
  • Oncology (AREA)
  • Plant Pathology (AREA)
  • Communicable Diseases (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicinal Preparation (AREA)
  • Pyrane Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT89301547T 1988-02-18 1989-02-17 Stabilisierte makrolidzusammensetzungen. ATE76291T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888803836A GB8803836D0 (en) 1988-02-18 1988-02-18 Compositions
EP89301547A EP0329460B1 (de) 1988-02-18 1989-02-17 Stabilisierte Makrolidzusammensetzungen

Publications (1)

Publication Number Publication Date
ATE76291T1 true ATE76291T1 (de) 1992-06-15

Family

ID=10631977

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89301547T ATE76291T1 (de) 1988-02-18 1989-02-17 Stabilisierte makrolidzusammensetzungen.

Country Status (18)

Country Link
EP (1) EP0329460B1 (de)
JP (1) JP2843591B2 (de)
KR (1) KR960011234B1 (de)
AT (1) ATE76291T1 (de)
AU (1) AU625746B2 (de)
BR (1) BR8900688A (de)
CA (1) CA1323835C (de)
DD (1) DD297821A5 (de)
DE (1) DE68901543D1 (de)
DK (1) DK175300B1 (de)
ES (1) ES2031351T3 (de)
GB (1) GB8803836D0 (de)
GR (1) GR3004648T3 (de)
HU (1) HU203189B (de)
IE (1) IE61053B1 (de)
NZ (1) NZ228038A (de)
PT (1) PT89760B (de)
ZA (1) ZA891248B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2097127T3 (es) * 1989-12-15 1997-04-01 American Cyanamid Co Formulaciones de administracion topica eficaces para el control de parasitos internos y externos de animales homotermos.
US6514951B1 (en) 1989-12-15 2003-02-04 American Cyanamid Company Pour-on formulations effective for the control of internal and external parasites of homothermic animals
US5346698A (en) * 1991-01-15 1994-09-13 Mycogen Corporation Synergistic pesticidal compositions
JP2540394B2 (ja) * 1991-05-28 1996-10-02 ニチアス株式会社 エルボカバ―の製造方法および製造装置
ES2086022T3 (es) * 1991-07-23 1996-06-16 American Cyanamid Co Composiciones estables para administracion parenteral y su uso.
RO115102B1 (ro) * 1993-05-10 1999-11-30 Merck & Co Inc Formulari topice pe baza de avermectina si procedee de preparare a acestora
PL174488B1 (pl) * 1993-05-10 1998-08-31 Merck & Co Inc Preparat do zwalczania pasożytów zwierząt oraz sposób wytwarzania preparatu do zwalczania pasożytów zwierząt
US5602107A (en) * 1993-05-10 1997-02-11 Merck & Co., Inc. Pour-on formulations consisting of gylcols, glycerides and avermectin compounds
GB9826882D0 (en) 1998-12-07 1999-01-27 Novartis Ag Organic compounds
PT1197215E (pt) * 2000-10-10 2006-07-31 Wyeth Corp Composicoes antelminticas
BG64140B1 (bg) * 2000-12-21 2004-02-27 "Биовет" Ад Състав за растителна защита с инсектицидно и акарицидно действие
CN100402031C (zh) 2002-07-30 2008-07-16 惠氏公司 含有瑞帕霉素羟基酯的胃肠外制剂
US20080125480A1 (en) * 2004-12-30 2008-05-29 Cheminova A/S Oil-In-Water Formulation Of Avermectins
AU2006331874A1 (en) * 2005-12-20 2007-07-05 Wyeth Control of CCI-779 dosage form stability through control of drug substance impurities
FR2906467B1 (fr) * 2006-09-28 2012-11-09 Galderma Sa Utilisation de composes de la famille des milbemycines pour le traitement de desordres dermatologiques chez l'homme
JP2024523472A (ja) 2021-06-25 2024-06-28 インターベット インターナショナル ベー． フェー． 口当たりの良い動物用組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH408284A (de) * 1958-06-26 1966-02-28 Philips Nv Verfahren zum Stabilisieren kristallinischer Verbindungen gegen Oxydation
NZ197796A (en) * 1980-08-04 1984-11-09 Merck & Co Inc Stabilised aqueous formulations containing ivermectin
JPS5920285A (ja) * 1982-07-23 1984-02-01 Sankyo Co Ltd ミルベマイシンｄの５−二塩基酸エステル誘導体及びその塩
AU2314184A (en) * 1983-01-10 1984-07-12 Robert Young & Company Limited Endoparasiticidal composition containing levamisole
NZ210505A (en) * 1983-12-22 1988-06-30 Merck & Co Inc Parasiticidal compositions containing avermectin or milbemycin derivatives
ZW15585A1 (en) * 1984-09-14 1986-04-23 Glaxo Group Ltd Antibiotic compounds and their preparation

Also Published As

Publication number Publication date
IE890510L (en) 1989-08-18
BR8900688A (pt) 1989-10-10
JPH023690A (ja) 1990-01-09
DK175300B1 (da) 2004-08-16
AU3006589A (en) 1989-08-24
JP2843591B2 (ja) 1999-01-06
IE61053B1 (en) 1994-09-21
ZA891248B (en) 1989-10-25
EP0329460A3 (en) 1989-10-18
ES2031351T3 (es) 1992-12-01
KR890012541A (ko) 1989-09-18
HU203189B (en) 1991-06-28
DK75689A (da) 1989-08-19
DK75689D0 (da) 1989-02-17
PT89760A (pt) 1989-10-04
CA1323835C (en) 1993-11-02
GR3004648T3 (de) 1993-04-28
EP0329460A2 (de) 1989-08-23
EP0329460B1 (de) 1992-05-20
DD297821A5 (de) 1992-01-23
HUT50629A (en) 1990-03-28
GB8803836D0 (en) 1988-03-16
KR960011234B1 (ko) 1996-08-21
NZ228038A (en) 1991-07-26
AU625746B2 (en) 1992-07-16
DE68901543D1 (de) 1992-06-25
PT89760B (pt) 1994-03-31

Similar Documents

Publication Publication Date Title
ATE76291T1 (de) Stabilisierte makrolidzusammensetzungen.
DK0392376T3 (da) N-acylderivater af LL-E33288-antitumor-antibiotika
DE68914856T3 (de) Synergetische Antioxydationsmischung.
AU3509889A (en) Substituted benzthiazol-2-yl compounds as antitumor agents
NO872201D0 (no) Stabilisering av multivitamin/sporelement-formuleringer.
ES2054746T3 (es) Aditivo para piensos estabilizado y procedimiento para su preparacion.
GB2199746B (en) Stabilization of antibiotic compositions with salts.
DK430689A (da) 2-aza-4-(alkoxycarbonyl)spiro(4,5)decan-3-oner
DE69208016D1 (de) Inhibierte 141b
ATE79373T1 (de) Beta-alkylmelatonine.
DK508885D0 (da) Esterderivat af antibiotikum l 17046 og fremgangsmaade til fremstillingderaf
FI101795B1 (fi) Menetelmiä diritromysiinin muodon II valmistamiseksi ja eristämiseksi sekä välituotteena käyttökelpoinen kiteinen diritromysiinin solvaatti
ES2061515T3 (es) Poliolefinas estabilizadas contra la degradacion oxidativa con mezclas de diarilaminas substituidas con aralquilo y fosfitos impedidos estericamente.
YU47592B (sh) 13-alkil-23-imino i 13-halo-23-imino derivati makrolidnih jedinjenja
DE3884940D1 (de) Herstellung einer elektrolumineszenten dünnschichtvorrichtung.
AU8114387A (en) Use of 5-(substituted phenyl)-oxazolidinone derivatives for treatment of depression
DK144765C (da) Fremgangsmaade til fremstilling af en antibiotisk blanding indeholdende forbindelse 41043 og forbindelse 41494, eller de enkelte komponenter i blandingen
ATE139519T1 (de) Stabilisiertes 141b
FI884618A0 (fi) Anordning foer taendning och stabilisering av en svetsbaoge.
IT8009418A0 (it) Derivati di 1,2,3,4,5,6-esaidroazepino-(4,5-b) indolo utilizzabili come intermediari disintesi
EP0188373A3 (en) Macrolide derivatives
YU46700B (sh) Kristalni monohidrat i kristalni mono- i bis (n-n'-dimetilformamid) solvati beta-laktamskog antibiotika
ES549998A0 (es) Procedimiento para la preparacion de 13 a-alquilgonanos
JO935B1 (en) Derivatives of the antibiotic capii. Mother . 123

Legal Events

Date Code Title Description
EELA Cancelled due to lapse of time